_PRIVATE_LIMITED.webp)
Biospec Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -93.90%
- Profit Growth -102.57%
- Ebitda -98.28%
- Net Worth -1.88%
- Total Assets -18.45%
About Biospec
Biospec Private Limited (BPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2007 and has a history of 17 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Biotek Instruments (I) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipul Chhatbar and Nikita Chhatbar serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72900MH2007PTC171963
-
Company No.
171963
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Biospec?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Chhatbar
|
Director | 25-Jun-2007 | Current |
|
Nikita Chhatbar
|
Director | 25-Jun-2007 | Current |
Financial Performance of Biospec.
Biospec Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 93.9% decrease. The company also saw a substantial fall in profitability, with a 102.57% decrease in profit. The company's net worth dipped by a decrease of 1.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biospec?
Unlock access to Biospec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Medispec Genexplore Diagnostics Center L LpVipul Chhatbar and Nikita Chhatbar are mutual person
-
Medispec India LimitedVipul Chhatbar and Nikita Chhatbar are mutual person
-
Genexplore Medisquare Diagnostics Center LlpVipul Chhatbar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biospec?
Unlock and access historical data on people associated with Biospec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biospec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biospec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.